Some of the major players operating in the market are Novo Nordisk A/S, Lilly, Sanofi, AstraZeneca, Pfizer Inc., Boehringer Ingelheim International GmbH, Amgen Inc., ZEALAND PHARMA, Merck & Co., Inc., Hanmi Pharm.Co.,Ltd
The market also encompasses ongoing advancements in gene therapy, enzyme replacement, and novel small-molecule treatments aimed at addressing the underlying genetic causes
common gap
While commercial programs typically offer standardized meal plans or point systems, medical programs begin with detailed physiological assessments to identify specific metabolic barriers
Those covered under the ODB are 65 years of age or older and are economically deprived
Forhan M, Gill SV